Automated Immunoassay Analyzers Market size was over USD 25.6 billion in 2023 and is projected to cross USD 124.9 billion by the end of 2036, growing at more than 14.1% CAGR during the forecast period i.e., between 2024-2036. In 2024, the industry size of automated immunoassay analyzers is evaluated at USD 29.2 billion.
The automated immunoassay analyzers market is likely to witness a stable expansion, driven by the growing burden of chronic diseases and the emerging need for accurate diagnostic solutions. With healthcare providers keen on ensuring improved patient care and timely diagnosis, automated immunoassay analyzers have become vital to clinical laboratories. These analyzers return high throughput with high precision, which has made them very essential for bulk quantities of testing in hospitals and diagnostic centers. Besides, technology advancements like integrations with a digital health platform provide more ways for market expansion.
Several companies are adding momentum to the growth of automated immunoassay analyzers by announcing the launch of newer, value-added products and strategic partnerships. For example, in July 2023, Anbio Biotechnology Ltd. launched AF-100S, a compact and affordable fluorescent immunoassay solution for transforming clinical diagnostics. The release of this new product follows the sustained efforts of industry players to further advance diagnostic capabilities and meet evolving needs among healthcare providers. As a result, such innovative launches by companies are likely to continue driving growth in the automated immunoassay analyzers market.
Growth Drivers:
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
14.1% |
|
Base Year Market Size (2023) |
USD 25.6 billion |
|
Forecast Year Market Size (2036) |
USD 124.9 billion |
|
Regional Scope |
|
Product (Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System, Radioimmunoassay)
The chemiluminescence segment has emerged as the leading product type in the automated immunoassay analyzers market and is expected to hold more than 37% share during the forecast period. This growth can be attributed to its superior sensitivity and specificity compared to other immunoassay techniques. Chemiluminescent analyzers find extensive applications in clinical laboratories for several studies related to hormone testing and infectious disease diagnosis. In March 2023, bioMérieux released the VIDAS SARS-CoV-2 IgG II, a chemiluminescent immunoassay, marking how continuous innovation in the segment is at the heart of pandemic management.
Application (Infectious Diseases, Endocrinology, Drug Monitoring, Chronic Diseases, Allergy Testing)
The infectious diseases segment in the automated immunoassay analyzers market is expected to register a steady revenue growth during the forecast period. This requirement for tools related to rapid and accurate diagnostics due to increasing global health concerns pertaining to infectious disease outbreaks such as COVID-19 has increased significantly. Their utilization in detecting and monitoring infectious diseases today provides timely information that is very helpful in making decisions about patients' treatments. Thus, these analyzers have turned out to be irreplaceable. Anbio Biotechnology Ltd. introduced the AF-100S FIA in July 2023 to strengthen its leading position in the point-of-care immunodiagnostic solution segment.
End user (Academic Research Institutes, Biotech and Pharma Companies, Hospitals, Diagnostic Test Laboratories, and Others)
The hospital segment is the largest end user category within the automated immunoassay analyzers market due to rising demand for high-throughput and precise diagnostic facilities within a hospital setup. An automated immunoassay analyzer can support a large number of tests in a very short span, which propels their integration into hospital diagnosis. In April 2023, Siemens Healthineers launched the Atellica Solution, a high degree of automation in an immunoassay system to address specific customer needs within large hospital laboratories, further strengthening the leading position of the segment.
Our in-depth analysis of the automated immunoassay analyzers market includes the following segments:
|
Product |
|
|
Application |
|
|
End user |
|
North America Market Analysis
North America is likely to retain the leading position in the automated immunoassay analyzers market, accounting for the largest share of 38% during the forecast period owing to rising cases of chronic diseases as well as the presence of key players on its grounds. In addition to this, the overall diffusion of technologically advanced health tools and a rising demand for accurate diagnosis can boost market growth going ahead.
The U.S. is anticipated to lead the market through 2036. A combination of high healthcare expenditure, along with a focus on enhancing diagnostic accuracy, drives the automated immunoassay analyzers market in the U.S. Major companies operating in the U.S. advance the market due to continuous innovation and new product launches. In March 2023, bioMérieux invested in Proxim Diagnostics to develop a fully automated immunodiagnostic tool called the Profile System. This reflects the continued efforts toward strengthening diagnostics with efficiency and accuracy, crucial in managing the rising tide of chronic infectious diseases.
In Canada, government initiatives to advance access to healthcare and diagnostic capabilities promote market growth. In its 2023 report, Health Canada indicated that millions are invested in modernizing diagnostic equipment in public hospitals to increase early diagnosis and effective treatment of diseases. This could be a commitment to the betterment of healthcare and is thus likely to drive the use of automated immunoassay analyzers across the country.
Asia Pacific Market Analysis
Asia Pacific automated immunoassay analyzers market is likely to witness rapid expansion during the forecast period due to the rising burden of chronic diseases and improving healthcare expenditure in the region. Other factors such as a huge population base and growing awareness associated with the early detection of diseases are expected to boost market growth. India, China, and Japan are some of the largest revenue-generating countries in the region, each presenting distinctive growth opportunities.
The automated immunoassay analyzers market is expanding rapidly in India, owing to governmental initiatives taken to improve the healthcare infrastructure and the rising prevalence of various chronic diseases. The National Health Mission by the Indian government has been one of the focused initiatives to promote the adoption of advanced diagnostic tools across rural and urban healthcare centers.
The automated immunoassay analyzers market growth in China is fueled by an increased focus on the modernization of healthcare and an unprecedented demand for competent diagnostic solutions within the country. The government has brought into action, various healthcare reforms to facilitate access to superior diagnostic tools. In May 2023, Mindray launched a new chemiluminescent immunoassay analyzer, extending its portfolio to meet the increasing demand for high-output testing in hospitals and diagnostic laboratories.
Several key players constitute the competitive landscape of automated immunoassay analyzers, with companies driving innovation and novel technologies thereby, boosting automated immunoassay analyzers market growth. Some leading players include bioMérieux, Siemens Healthineers, Abbott Laboratories, and Roche Diagnostics, endowing the market with extensive product portfolios and a powerful presence across different geographies. These companies are invariably investing in research and development to introduce new products and develop better versions of their existing technologies to stay ahead of the curve.
In July 2023, Abbott Laboratories launched the Alinity m, a fully automated immunoassay system capable of providing faster and more accurate results for a broad array of diagnostic uses. The company announced this launch to expand its share in the automated immunoassay analyzers market. This also reflects the intense competition between the leading companies involved within the industry framework. Due to continuous technological developments and the introduction of new products, the market is destined to be dynamic and highly competitive.
Here are some leading players in the automated immunoassay analyzers market:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?